Cetuximab-modified silica nanoparticle loaded with ICG for tumor-targeted combinational therapy of breast cancer

References

• Brockhoff G, Heckel B, Schmidt-Bruecken E, et al. (2007). Differential impact of Cetuximab, Pertuzumab and Trastuzumab on BT474 and SK-BR-3 breast cancer cell proliferation. Cell Prolif 40:488–507.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Zhang AQ, Hu JJ, et al. (2017). Multifunctional peptide-amphiphile end-capped mesoporous silica nanoparticles for tumor targeting drug delivery. Acs Appl Mater Interfaces 9:2093–2103.
   Web of Science ®Google Scholar
• Colzani B, Pandolfi L, Hoti A, et al. (2018). Investigation of antitumor activities of trastuzumab delivered by PLGA nanoparticles. Ijn 13:957–73.
   Web of Science ®Google Scholar
• Daryasari MP, Akhgar MR, Mamashli F, et al. (2016). Chitosan-folate coated mesoporous silica nanoparticles as a smart and pH-sensitive system for curcumin delivery. Rsc Adv 6:105578–88.
   Web of Science ®Google Scholar
• Ding X, Xu X, Zhao Y, et al. (2017). Tumor targeted nanostructured lipid carrier co-delivering paclitaxel and indocyanine green for laser triggered synergetic therapy of cancer. Rsc Adv 7:35086–95.
   Web of Science ®Google Scholar
• Du X, Xiong L, Dai S, Qiao SZ. (2015). γ-PGA-coated mesoporous silica nanoparticles with covalently attached prodrugs for enhanced cellular uptake and intracellular GSH-responsive release. Adv Healthcare Mater 4:771–81.
   Web of Science ®Google Scholar
• Duo Y, Li Y, Chen C, et al. (2017). DOX-loaded pH-sensitive mesoporous silica nanoparticles coated with PDA and PEG induce pro-death autophagy in breast cancer. Rsc Adv 7:39641–50.
   Web of Science ®Google Scholar
• Hashemi M, Yadegari A, Yazdanpanah G, et al. (2016). Functionalized R9-reduced graphene oxide as an efficient nano-carrier for hydrophobic drug delivery. RSC Adv 6:74072–84.
   Web of Science ®Google Scholar
• Hongshuai W, Chaoqun Y, Jia J, et al. (2019). A novel near-infrared triggered dual-targeted nanoplatform for mitochondrial combined photothermal-chemotherapy of cancer in vitro. Nanotechnology 30:035601.
   PubMed Web of Science ®Google Scholar
• Hou X, Wang X, Liu R, et al. (2017). Facile synthesis of multifunctional Fe3O4@SiO2@Au magneto-plasmonic nanoparticles for MR/CT dual imaging and photothermal therapy. Rsc Adv 7:18844–50.
   Web of Science ®Google Scholar
• Huang S, Li C, Wang W, et al. (2017). A54 peptide-mediated functionalized gold nanocages for targeted delivery of DOX as a combinational photothermal-chemotherapy for liver cancer. Ijn 12:5163–76.
   Web of Science ®Google Scholar
• Johnson HA, Pavelec M. (1973). Thermal enhancement of thio-TEPA cytotoxicity. J Natl Cancer Inst 50:903–8.
   PubMedGoogle Scholar
• Knezevic N, Mrdjanovic J, Borisev I, et al. (2016). Hydroxylated fullerene-capped, vinblastine-loaded folic acid-functionalized mesoporous silica nanoparticles for targeted anticancer therapy. Rsc Adv 6:7061–5.
   Web of Science ®Google Scholar
• Li J, Zong S, Wang Z, Cui Y. (2017). “Blinking” silica nanoparticles for optical super resolution imaging of cancer cells. Rsc Adv 7:48738–44.
   Web of Science ®Google Scholar
• Li Y, Gao Z, Chen F, et al. (2018). Decoration of cisplatin on 2D metal-organic frameworks for enhanced anticancer effects through highly increased reactive oxygen species generation. ACS Appl Mater Interf 10:30930–5.
   PubMed Web of Science ®Google Scholar
• Liao C, Sun Q, Liang B, et al. (2011). Targeting EGFR-overexpressing tumor cells using Cetuximab-immunomicelles loaded with doxorubicin and superparamagnetic iron oxide. Eur J Radiol 80:699–705.
   PubMed Web of Science ®Google Scholar
• Liu C, Qing Z, Zheng J, et al. (2015). DNA-templated in situ growth of silver nanoparticles on mesoporous silica nanospheres for smart intracellular GSH-controlled release. Chem Commun 51:6544–7.
   PubMed Web of Science ®Google Scholar
• Martínezcarmona M, Lozano D, Colilla M, Valletregí M. (2016). Selective topotecan delivery to cancer cells by targeted pH-sensitive mesoporous silica nanoparticles. Rsc Adv 6:50923–32.
   Web of Science ®Google Scholar
• Meng L-x, Ren Q, Meng Q, et al. (2018). Trastuzumab modified silica nanoparticles loaded with doxorubicin for targeted and synergic therapy of breast cancer. Artif Cells Nanomed Biotechnol 45:1–8.
   PubMed Web of Science ®Google Scholar
• Pérez-Ortiz M, Zapata-Urzúa C, Acosta GA, et al. (2017). Gold nanoparticles as an efficient drug delivery system for GLP-1 peptides. Colloids Surf B Biointerf 158:25–32.
   PubMed Web of Science ®Google Scholar
• Saxena V, Sadoqi M, Shao J. (2004). Enhanced photo-stability, thermal-stability and aqueous-stability of indocyanine green in polymeric nanoparticulate systems. J Photochem Photobiol B Biol 74:29–38.
   PubMed Web of Science ®Google Scholar
• Sheng Y, Chang L, Kuang T, Hu J. (2016). PEG/heparin-decorated lipid–polymer hybrid nanoparticles for long-circulating drug delivery. Rsc Adv 6:23279–87.
   Web of Science ®Google Scholar
• Shuang J, Wang X, Zhang Z, et al. (2016). CD20 monoclonal antibody targeted nanoscale drug delivery system for doxorubicin chemotherapy: an in vitro study of cell lysis of CD20-positive Raji cells. Ijn 11:5505–18.
   Web of Science ®Google Scholar
• Sun X, Luo Y, Huang L, et al. (2017). A peptide-decorated and curcumin-loaded mesoporous silica nanomedicine for effectively overcoming multidrug resistance in cancer cells. Rsc Adv 7:16401–9.
   Web of Science ®Google Scholar
• Tang D, Zhao X, Yang T, Wang C. (2018). Paclitaxel prodrug based mixed micelles for tumor-targeted chemotherapy. RSC Adv 8:380–9.
   Web of Science ®Google Scholar
• Tol J, Dijkstra JR, Klomp M, et al. (2010). Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximab. Eur J Cancer 46:1997–2009.
   PubMed Web of Science ®Google Scholar
• Wan J, Wu W, Zhang R, et al. (2017). Anti-EGFR antibody conjugated silica nanoparticles as probes for lung cancer detection. Exp Therap Med 14:3407–12.
   PubMed Web of Science ®Google Scholar
• Wang C, Chen S, Wang Y. (2018). Lipase-triggered water-responsive “Pandora's Box” for cancer therapy: toward induced neighboring effect and enhanced drug penetration. Adv Mater 30:1706407.
   Web of Science ®Google Scholar
• Wang C, Chen S, Yu Q, et al. (2017). Taking advantage of the disadvantage: employing the high aqueous instability of amorphous calcium carbonate to realize burst drug release within cancer cells. J Mater Chem B 5:2068–73.
   PubMed Web of Science ®Google Scholar
• Wang C, Liu X, Chen S, et al. (2018). Facile preparation of phospholipid-amorphous calcium carbonate hybrid nanoparticles: toward controllable burst drug release and enhanced tumor penetration. Chem Commun (Camb) 54:13080–3.
   PubMed Web of Science ®Google Scholar
• Wang J-k, Zhou Y-y, Guo S-j, et al. (2017). Cetuximab conjugated and doxorubicin loaded silica nanoparticles for tumor-targeting and tumor microenvironment responsive binary drug delivery of liver cancer therapy. Mater Sci Eng C 76:944–50.
   PubMed Web of Science ®Google Scholar
• Wang Z, Tian Y, Zhang H, et al. (2016). Using hyaluronic acid-functionalized pH stimuli-responsive mesoporous silica nanoparticles for targeted delivery to CD44-overexpressing cancer cells. Ijn 11:6485–97.
   Web of Science ®Google Scholar
• Xie J, Fan Z, Li Y, et al. (2018). Design of pH-sensitive methotrexate prodrug-targeted curcumin nanoparticles for efficient dual-drug delivery and combination cancer therapy. Ijn 13:1381–98.
   Web of Science ®Google Scholar
• Xu H, Wu K, Tian Y, et al. (2016). CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer. Int J Oncol 49:1343–50.
   PubMed Web of Science ®Google Scholar
• You C, Wang M, Wu H, et al. (2017). Near infrared radiated stimulus-responsive liposomes based on photothermal conversion as drug carriers for co-delivery of CJM126 and cisplatin. Mater Sci Eng C Mater Biol Appl 80:362–70.
   PubMed Web of Science ®Google Scholar
• You C-Q, Wu H-S, Gao Z-G, et al. (2018). Subcellular co-delivery of two different site-oriented payloads based on multistage targeted polymeric nanoparticles for enhanced cancer therapy. J Mater Chem B 6:6752–66.
   PubMed Web of Science ®Google Scholar
• Yu X, Zhu W, Di Y, et al. (2017). Triple-functional albumin-based nanoparticles for combined chemotherapy and photodynamic therapy of pancreatic cancer with lymphatic metastases. Ijn 12:6771–85.
   Web of Science ®Google Scholar
• Zhao Q, Geng H, Wang Y, et al. (2014). Hyaluronic acid oligosaccharide modified redox-responsive mesoporous silica nanoparticles for targeted drug delivery. Acs Appl Mater Interf 6:20290–9.
   PubMed Web of Science ®Google Scholar
• Zhao X, Tang D, Yang T, Wang C. (2018). Facile preparation of biocompatible nanostructured lipid carrier with ultra-small size as a tumor-penetration delivery system. Colloids Surf B Biointerf 170:355–63.
   PubMed Web of Science ®Google Scholar
• Zheng M, Yue C, Ma Y, et al. (2013). Single-step assembly of DOX/ICG loaded lipid–polymer nanoparticles for highly effective chemo-photothermal combination therapy. Acs Nano 7:2056–67.
   PubMed Web of Science ®Google Scholar